The importance of clinical suspicion on the diagnosis and treatment of herditary colorectal cancer;A importância da suspeição clínica no diagnóstico e tratamento do câncer colorretal hereditário

Revista Brasileira de Coloproctologia

Volumn 28, Issue 4, 2008, Pages 454-461

  Valadão, Marcus ^a,b   Graziosi, Guilherme ^a   Carneiro, Marcio ^a   Leal, Ricardo Ary ^a   Santa Rosa, Antonio Abílio P ^a   Almeida, Ricardo ^a   Muharre, Roberto Jamie ^a  

^a HOSPITAL GERAL DE BONSUCESSO   (Brazil)

^b NONE   (Brazil)

Author keywords

Colorectal hereditary cancer; Diagnosis; Treatment

Indexed keywords

EID: 63749089941     PISSN: 01019880     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0101-98802008000400008     Document Type: Article

References (31)

1. Yu HJA, Lin KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev. 2003; 29(6):461-70.
2. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med. 1966; 117(2):206-12.
3. Lynch HT, de la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet. 1999; 36(11):801-18.
4. Rousseau DL, Midis GP, Feig BW, et al. Cancer of the colon, rectum, and anus. In: Feig BW, Berger DH, Fuhrman GM, editors. The M.D. Anderson Surgical Oncology Handbook, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2003.
5. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997; 113(4):1146-58.
6. Brose MS, Smyrk TC, Weber B, Lynch HT. Genetic predisposition to cancer. In: Holland JF, Frei EIII, Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, editors. Cancer Medicine. 5th ed. Canada: BC Decker; 2000.
7. Lynch HT, Lynch J. Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol. 2000; 18(21 Suppl):19S-31S.
8. Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol. 2000; 18(4):305/13.
9. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (GCI-CCHNP). Dis Colon Rectum. 1991; 34(5): 424-5.
10. Watson P, Lin KM, Rodrigues-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, Lynch HT. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998; 83(2):259-66.
11. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999; 116(6):1453-6.
12. Boland CR, Thibodeau SN, Hamilton SR, Sidransky d, Eshleman JR, Burt RW, Meltzer, SJ, Rodriguez-Bigas MA, Fodde R Ranzani GN, Srivastava S. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res v. 58, p. 5248-5257, 1998.
13. Rodriguez-Bigas MA., Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997; 89(23):1758-62.
14. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96(4):261-8.
15. Valadõ M, Castro LS. Câncer colorretal hereditário. Rev Col Bras Cir2007; 34: 193-200.
16. Rodriguez-Bigas M, Vasen HF, Pekka-Mecklin J, Myrhøj T, Rozen P, Bertario L, Järvinen HJ, Jass JR, Kunitomo K, Nomizu T, Driscoll DL. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. Ann Surg. 1997; 225(2):202-7.
17. Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol. 2004; 22(24):4934-43.
18. Wüllenweber HP, Sutter C, Autschbach F, Willeke F, Kienle P, Benner A, Bahring J, Kadmon M, Herfarth C, von Knebe Doeberitz M, Gebert J. Evaluation of Bethesda guidelines in relation to microsatellite instability. Dis Colon Rectum 2001; 44(9):1281-9.
19. Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John DJ, Macrae FA, Giles GG, Hopper JL. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005; 23(27):6524-32. Epub 2005 Aug 22.
20. Vasen H, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Muller H, Khan PM, et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on CCHNP. Dis Colon Rectum. 1993; 36(1):1-4.
21. Simmang C, Senagore P Lowry A, Hicks T, Burnstein M, Dentsman F, Fazio V, Glennon E, Hyman N, Kerner B, Kilkenny J, Moore R, Peters W, Ross T, Savoca P, Vernava A, Wong WD. Practice parameters for detection of colorectal neoplasms. The Standards Committee, the American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1999; 42(9):1123-9.
22. DeCosse JJ. Surgical prophylaxis of familial colon cancer: prevention of death from familial colorectal cancer. J Natl Cancer Inst Monogr. 1995; (17):31-2.
23. Instituto Nacional do Cancer; http://www.inca.gov.br, acessado em 10 junho 2008 às 18:00h.
24. a ed., São Paulo, Ernesto Reichman, 2004.
25. Burke W, Peterson G, Lynch P, Botkin J, Daly M, Garber J, Khan MJ, McTiernan A, Offit K, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colorectal cancer. Cancer Genetics Studies Consortium. JAMA. 1997; 277(11):915-9.
26. Lerman, C.; Rimer, B.K. Psychological impact of Cancer Screening In: Croyle, R.T. Psychological Impact of Screening for Disease Prevention and Detection. New York: Oxford University Press, 1995. p. 65-81.
27. Houtz, P.S.; Wojtkowiak, S.L.; Simmonds, M.A.; Weinberg, G.B.; Heitjan, D.F. Using a State Cancer Center Registry to Increase Screening Behaviors of Sisters and Daughters of Breast Cancer Patients. American Journal of Public Health, 81(3), 386-388, 1991.
28. Lynch HT, Krush AJ Cancer Family "G" Revisited: 1895-1970. Cancer, v. 27, p. 1505-1511, 1971.
29. Offit, K Clinical Cancer Genetics; Risk Counselling and Management. New York: Wiley-Liss, 1998.
30. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P, Fodde R. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med. 1998; 339(8):511-8.
31. Van den Bosch T, Vandendael A, Van Schoubroeck D, Wranz PA, Lombard CJ. Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet Gynecol. 1995; 85(3):345-52.